{
  "content": "<think>\nOkay, so I've got this graph in Node/Edge format and I need to convert it into natural language sentences. Let me take a look at the data provided.\n\nFirst, there are nodes with IDs and labels. The main node seems to be labeled 'Patient' with details like address, birthdate, etc. Then there's another node labeled 'Medication' which is Plavix 75 MG Oral Tablet, and another one labeled 'Ingredient'. \n\nLooking at the edges, I see relationships between these nodes. One edge connects the Patient to the Medication, indicating that the patient takes this medication. Another edge shows an allergic relationship between the Patient and the Ingredient, meaning the ingredient is found in the medication but the patient might be allergic to it.\n\nI need to make sure each node and its connections are clearly described without using too much technical jargon. I should also include all necessary details like the medication's name, dosage, and any relevant dates or addresses.\n\nWait, the edge between Patient and Ingredient has some properties about 'stop' date. That means there was a period where the medication was taken before stopping on that specific date. I should mention that in the sentence to be accurate.\n\nI also notice that the 'tau_o' values are mostly 1 for ingredients and medications, indicating they have their own nodes, while the patient has tau_k as empty, meaning it doesn't reference other nodes except itself or maybe others not listed here.\n\nPutting this all together, I'll start by introducing the main node (Patient) with its details, then describe each relationship clearly. I'll make sure to connect the medication and ingredient correctly based on the edges provided.\n</think>\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes a patient (labeled as 'Patient') who is taking a medication called Plavix 75 MG Oral Tablet. The patient has an allergic reaction to an ingredient found in this medication, and there was a period where the patient stopped taking the medication on February 17, 2017.\n\nThe graph describes",
  "additional_kwargs": {},
  "response_metadata": {
    "model": "deepseek-r1",
    "created_at": "2025-03-28T13:59:58.225298Z",
    "done": true,
    "done_reason": "length",
    "total_duration": 1999755688042,
    "load_duration": 17154250,
    "prompt_eval_count": 884,
    "prompt_eval_duration": 194327167,
    "eval_count": 81920,
    "eval_duration": 1999541631583,
    "message": {
      "role": "assistant",
      "content": "",
      "images": null,
      "tool_calls": null
    }
  },
  "type": "ai",
  "name": null,
  "id": "run-bea32d69-b785-4535-a29c-d569e68e8841-0",
  "example": false,
  "tool_calls": [],
  "invalid_tool_calls": [],
  "usage_metadata": {
    "input_tokens": 884,
    "output_tokens": 81920,
    "total_tokens": 82804
  }
}